# Moleculera Labs, Inc.: Form D filings

Moleculera Labs, Inc., a biotechnology company in Oklahoma City, OK, filed 3 Form D notices with the SEC between 2011 and 2013. The latest, on October 18, 2013, reports $3 million sold of a $3.2 million offering to 28 investors.

Find out what Moleculera Labs, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Moleculera%20Labs%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Moleculera%20Labs%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmoleculera-labs-inc-1537411)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Moleculera%20Labs%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Moleculera%20Labs%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fmoleculera-labs-inc-1537411)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma): 227 rows, by operating companies, filed since November 1, 2024, $11.35, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/oklahoma
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 800 Research Parkway, Suite 384, Oklahoma City, OK, 73104
- Phone: (405) 239-5250
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2012
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1537411

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Oct 18, 2013 | New notice | $3,208,936 | $2,958,936 | $250,000 | 28 | Sep 20, 2013 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1537411/000120919113048726/0001209191-13-048726-index.htm) |
| Oct 30, 2012 | New notice | $540,000 | $324,000 | $216,000 | 9 | Oct 16, 2012 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1537411/000153741112000002/0001537411-12-000002-index.htm) |
| Dec 16, 2011 | New notice | $250,000 | $100,000 | $150,000 | 1 | Dec 5, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1537411/000153741111000001/0001537411-11-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Craig Shimasaki, PhD, MBA | Executive Officer, Director |  |
| Fred Hiller | Executive Officer |  |
| David Thomison | Director |  |

## Other biotechnology companies in Oklahoma that filed recently

- [Endless Corp](https://specstream.ai/data/form-d/company/endless-corp-2043905) $100,000 · Aug 19, 2026

[Every Form D from the week of Oct 14, 2013](https://specstream.ai/data/form-d/week/2013-10-14) · [All recent filings in Oklahoma](https://specstream.ai/data/form-d/state/oklahoma) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Moleculera Labs, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).